Giulia Viale

4.9k total citations · 2 hit papers
69 papers, 3.2k citations indexed

About

Giulia Viale is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Giulia Viale has authored 69 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 35 papers in Cancer Research and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Giulia Viale's work include Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (20 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Giulia Viale is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), HER2/EGFR in Cancer Research (20 papers) and Cancer Immunotherapy and Biomarkers (16 papers). Giulia Viale collaborates with scholars based in Italy, United States and United Kingdom. Giulia Viale's co-authors include Giuseppe Curigliano, Antonio Marra, Dario Trapani, Carmen Criscitiello, Bruno A. Duso, Paolo D’Amico, Carmen Belli, Emanuela Ferraro, Stefania Morganti and Franco Orsi and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Giulia Viale

66 papers receiving 3.1k citations

Hit Papers

HER2-Low Breast Cancer: Pathological and Clinical Landscape 2018 2026 2020 2023 2020 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HER2-Low Breast Cancer: Pathological and Clinical Landscape
    2020 490 citations Paolo Tarantino, Erika Hamilton et al. Journal of Clinical Oncology profile →
  2. Targeting the microenvironment in solid tumors
    2018 385 citations Carmen Belli, Dario Trapani et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Viale Italy 26 1.9k 1.3k 814 660 411 69 3.2k
Yoon‐La Choi South Korea 35 1.6k 0.8× 1.1k 0.9× 1.4k 1.8× 930 1.4× 342 0.8× 125 3.7k
Deborah Toppmeyer United States 26 2.3k 1.2× 1.2k 1.0× 1.1k 1.4× 678 1.0× 367 0.9× 94 3.4k
Stéphanie Lheureux Canada 27 1.6k 0.8× 1.1k 0.9× 1.8k 2.2× 560 0.8× 546 1.3× 153 4.3k
Thomas Hatschek Sweden 29 2.4k 1.3× 1.9k 1.5× 1.1k 1.4× 956 1.4× 388 0.9× 100 4.5k
Maria Vittoria Dieci Italy 36 3.1k 1.6× 1.6k 1.3× 1.1k 1.3× 1.1k 1.6× 750 1.8× 154 4.5k
Toshiaki Saeki Japan 32 1.7k 0.9× 600 0.5× 1.2k 1.4× 476 0.7× 234 0.6× 170 3.1k
Marleen Kok Netherlands 30 2.3k 1.2× 887 0.7× 1.1k 1.4× 817 1.2× 953 2.3× 90 3.6k
Mohammed A. Aleskandarany United Kingdom 36 1.6k 0.9× 1.5k 1.2× 1.7k 2.0× 510 0.8× 286 0.7× 81 3.4k
Thaer Khoury United States 32 1.5k 0.8× 1.1k 0.9× 1.1k 1.3× 453 0.7× 273 0.7× 153 3.1k
Gen‐Hong Di China 34 1.6k 0.9× 1.6k 1.3× 1.6k 2.0× 417 0.6× 341 0.8× 121 3.6k

Countries citing papers authored by Giulia Viale

Since Specialization
Citations

This map shows the geographic impact of Giulia Viale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Viale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Viale more than expected).

Fields of papers citing papers by Giulia Viale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Viale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Viale. The network helps show where Giulia Viale may publish in the future.

Co-authorship network of co-authors of Giulia Viale

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Viale. A scholar is included among the top collaborators of Giulia Viale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Viale. Giulia Viale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Licata, Luca, Giulia Viale, Rebecca Dent, et al.. (2025). Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer. Clinical Cancer Research. 31(18). 3916–3921.
2.
Giugliano, Federica, Barbara Pistilli, Giulia Viale, et al.. (2025). Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies. Cancer Treatment Reviews. 139. 102980–102980. 3 indexed citations
3.
4.
Curigliano, Giuseppe, Rebecca Dent, Shanu Modi, et al.. (2024). Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer. ESMO Open. 9(4). 102989–102989. 13 indexed citations
5.
Viale, Giulia, Mark Basik, Naoki Niikura, et al.. (2023). Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer. ESMO Open. 8(4). 101615–101615. 41 indexed citations
6.
Fusco, Nicola, Konstantinos Venetis, Elham Sajjadi, et al.. (2022). 29P The molecular landscape of breast mucoepidermoid carcinoma. Annals of Oncology. 33. S136–S137. 1 indexed citations
7.
Marra, Antonio, Giulia Viale, Stefano Pileri, et al.. (2020). Breast implant-associated anaplastic large cell lymphoma: A comprehensive review. Cancer Treatment Reviews. 84. 101963–101963. 54 indexed citations
8.
Criscitiello, Carmen, Andrea Vingiani, Patrick Maisonneuve, Giulia Viale, & Giuseppe Curigliano. (2020). Tumor-infiltrating lymphocytes (TILs) in ER+/HER2− breast cancer. Breast Cancer Research and Treatment. 183(2). 347–354. 74 indexed citations
9.
Tarantino, Paolo, Erika Hamilton, Sara M. Tolaney, et al.. (2020). HER2-Low Breast Cancer: Pathological and Clinical Landscape. Journal of Clinical Oncology. 38(17). 1951–1962. 490 indexed citations breakdown →
10.
Mazzarella, Luca, Bruno A. Duso, Dario Trapani, et al.. (2019). The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review. European Journal of Cancer. 117. 14–31. 80 indexed citations
11.
Viale, Giulia, Antonio Marra, Giuseppe Curigliano, & Carmen Criscitiello. (2019). Toward precision medicine in inflammatory breast cancer. Translational Cancer Research. 8(6). 1 indexed citations
12.
Viale, Giulia, Antonio Marra, Giuseppe Curigliano, & Carmen Criscitiello. (2019). Toward precision medicine in inflammatory breast cancer. Translational Cancer Research. 8(S5). S469–S478. 4 indexed citations
13.
Tarantino, Paolo, Dario Trapani, Stefania Morganti, et al.. (2019). Opportunities and challenges of implementing Pharmacogenomics in cancer drug development. Cancer Drug Resistance. 2(1). 43–52. 2 indexed citations
14.
Criscitiello, Carmen, Andrea Vingiani, Patrick Maisonneuve, et al.. (2019). TILs in ER+/HER2- breast cancer. Annals of Oncology. 30. iii3–iii3. 1 indexed citations
15.
Criscitiello, Carmen, Mehra Golshan, William T. Barry, et al.. (2018). Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis. European Journal of Cancer. 97. 1–6. 30 indexed citations
16.
Morganti, Stefania, Paolo Tarantino, Emanuela Ferraro, et al.. (2018). Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life. Critical Reviews in Oncology/Hematology. 133. 171–182. 88 indexed citations
17.
Duso, Bruno A., Dario Trapani, Giulia Viale, et al.. (2018). Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opinion on Pharmacotherapy. 19(3). 299–305. 4 indexed citations
18.
Piccart, Martine, Giulia Viale, Peter Ellis, Marc Abramowicz, & Lisa A. Carey. (2016). ecancermedicalscience. ecancermedicalscience. 5. 217–217. 6 indexed citations
19.
20.
Viale, Giulia. (2012). The current state of breast cancer classification. Annals of Oncology. 23. x207–x210. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoon‐La Choi Breakdown of academic impact, for papers by Deborah Toppmeyer Breakdown of academic impact, for papers by Stéphanie Lheureux Breakdown of academic impact, for papers by Thomas Hatschek Breakdown of academic impact, for papers by Maria Vittoria Dieci Breakdown of academic impact, for papers by Toshiaki Saeki Breakdown of academic impact, for papers by Marleen Kok Breakdown of academic impact, for papers by Mohammed A. Aleskandarany Breakdown of academic impact, for papers by Thaer Khoury Breakdown of academic impact, for papers by Gen‐Hong Di
Rankless by CCL
2026